About Bausch Health Cos (BHC)

Bausch Health Cos Inc, formerly known as Valeant Pharmaceuticals International Inc, is a company focused on developing, manufacturing, and marketing a range of pharmaceutical products. The company operates through four segments: Ortho Dermatologics, Bausch + Lomb/International, Salix Pharmaceuticals, and Diversified Products. The Ortho Dermatologics segment offers a variety of dermatological products to treat various conditions such as acne, psoriasis, and actinic keratosis. The Bausch + Lomb/International segment produces and markets eye health products, including contact lenses, lens care products, ophthalmic pharmaceuticals, and surgical devices. The Salix Pharmaceuticals segment specializes in gastroenterology products that treat conditions like irritable bowel syndrome, ulcerative colitis, and hepatic encephalopathy. The Diversified Products segment offers a range of consumer healthcare products, over-the-counter medications, and medical devices.

Bausch Health Cos Inc has experienced various changes in its stock price history. The stock had been trading under the ticker symbol VRX until the company changed its name to Bausch Health Cos Inc in 2018. In recent years, the stock price has shown volatility, reflecting changes in market sentiment and investor confidence. The company has faced challenges related to debt levels, legal issues, and reputational concerns, which have impacted its stock performance. However, Bausch Health Cos Inc has also made efforts to turn around its business and strengthen its financial position. The company has focused on reducing debt, divesting non-core assets, and improving its product portfolio. These initiatives have contributed to improved financial results and investor sentiment, leading to a recovery in the stock price.